Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-1020 in hospitalized chronic schizophrenia
NCT00480571Phase 2Completed
- Sponsor
- BioLineRx Ltd.
- Start
- Jun 2007
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Perphenazine in schizophrenia, schizoaffective disorder, sponsored by BioLineRx Ltd.. Started Jun 2007; status: completed.
02
Drugs
Perphenazine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT00480571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00480571.